Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Accolade Inc (ACCD)

Accolade Inc (ACCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Accolade: Fiscal Q3 Earnings Snapshot

Accolade: Fiscal Q3 Earnings Snapshot

ACCD : 8.09 (-1.94%)
1 Market-Beating Stock to Buy Near Its 52-Week High

This stock has been firing on all cylinders -- and it isn't about to stop.

NVO : 125.81 (+1.04%)
ACCD : 8.09 (-1.94%)
LLY : 762.36 (+1.43%)
Why Eli Lilly Stock Crawled Higher Today

The pharmaceutical giant gets a lift from some good news on insurance coverage and a prognosticator's price-target lift.

WFC : 57.44 (+1.72%)
NVO : 125.81 (+1.04%)
ACCD : 8.09 (-1.94%)
LLY : 762.36 (+1.43%)
GLP-1 Coverage in Employer Plans Could Nearly Double in 2024

/PRNewswire/ -- Accolade (Nasdaq: ACCD) announced today findings from an employer survey on sentiment and adoption of GLP-1 medications. A key finding: while...

ACCD : 8.09 (-1.94%)
Why Shares of Accolade Fell This Week

The company's fiscal 2024 second-quarter numbers showed improvement, but analysts and investors were not impressed.

ACCD : 8.09 (-1.94%)
Accolade: Fiscal Q2 Earnings Snapshot

Accolade: Fiscal Q2 Earnings Snapshot

ACCD : 8.09 (-1.94%)
Accolade Expands Physician-Executive Leadership to Enhance Care Delivery and Improve the Healthcare Experience

/PRNewswire/ -- Accolade (Nasdaq: ACCD) announced the expansion of its care delivery team, strengthening the company's ability to streamline healthcare...

ACCD : 8.09 (-1.94%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The widely followed growth investor went stock shopping on the final trading day in August.

MS : 87.44 (+1.45%)
PLTR : 22.52 (-0.66%)
NTLA : 23.42 (-3.50%)
ACCD : 8.09 (-1.94%)
Cathie Wood Just Sold Nvidia -- and Bought These 5 Potentially Explosive Growth Stocks Again

The famous growth investor has been making some interesting stock moves lately.

NTLA : 23.42 (-3.50%)
CRSP : 60.07 (-0.99%)
ACCD : 8.09 (-1.94%)
RXRX : 8.16 (-2.97%)
NVTA : 0.0195 (+2.63%)
ARKK : 45.77 (-1.59%)
ARKG : 25.43 (-1.81%)
NVDA : 889.58 (+0.88%)
Cathie Wood Just Sold Shopify -- and Bought These 7 Potentially Explosive Growth Stocks

The Ark Invest CEO continues to trim Shopify holdings to fund some big purchases.

ADYEY : 15.2500 (+1.86%)
SHOP : 69.88 (-0.17%)
ARKW : 77.98 (-1.47%)
ARKF : 28.23 (-1.02%)
ARKK : 45.77 (-1.59%)
ARKG : 25.43 (-1.81%)
DNA : 0.9999 (-1.00%)
ACCD : 8.09 (-1.94%)
RXRX : 8.16 (-2.97%)
CRSP : 60.07 (-0.99%)
ADPT : 3.10 (+2.99%)
NTLA : 23.42 (-3.50%)

Barchart Exclusives

2 Dividend Aristocrats to Borrow from Warren Buffett's Portfolio
These two standout Dividend Aristocrats from Warren Buffett's Berkshire Hathaway equity portfolio exemplify his investment philosophy of favoring companies with strong fundamentals, consistent dividend growth, and the ability to deliver steady returns in uncertain economic times. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar